An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms

Completed · Phase 2

Conditions studied: Lower Urinary Tract Symptoms

In brief

Multicenter trial conducted in Pharmacy retail centers

Key facts

Study ID

NCT01726270

Run by

Boehringer Ingelheim

People needed

689

Starts

2012-11-01

Expected to finish

2013-03-01

Last updated by the study team

2020-03-27

Who can join

Age: 18 and older, up to 100. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Men 18 years of age and older.
• Able to speak, read and understand English.
• Willing to participate in the study and voluntarily sign an informed consent document.

You may not qualify if…

• Subject or anyone in their household is currently employed by a marketing or marketing research company, and advertising agency or public relations firm, a pharmacy or pharmaceutical company, a manufacturer of medicines, a managed care or health insurance company as a healthcare professional or healthcare practice.

Where it is running

• Boehringer Ingelheim Investigational Site — Hoover, Alabama, United States
• Boehringer Ingelheim Investigational Site — Mesa, Arizona, United States
• Boehringer Ingelheim Investigational Site — Encino, California, United States
• Boehringer Ingelheim Investigational Site — Garden Grove, California, United States
• Boehringer Ingelheim Investigational Site — La Habra, California, United States
• Boehringer Ingelheim Investigational Site — Anoka, Minnesota, United States
• Boehringer Ingelheim Investigational Site — Elk River, Minnesota, United States
• Boehringer Ingelheim Investigational Site — Fridley, Minnesota, United States
• Boehringer Ingelheim Investigational Site — Roseville, Minnesota, United States
• Boehringer Ingelheim Investigational Site — Saint Francis, Minnesota, United States
• Boehringer Ingelheim Investigational Site — Albuquerque, New Mexico, United States
• Boehringer Ingelheim Investigational Site — Longview, Texas, United States
• Boehringer Ingelheim Investigational Site — Tyler, Texas, United States
• Boehringer Ingelheim Investigational Site — Bountiful, Utah, United States
• Boehringer Ingelheim Investigational Site — Layton, Utah, United States
• Boehringer Ingelheim Investigational Site — Salt Lake City, Utah, United States
• Boehringer Ingelheim Investigational Site — Syracuse, Utah, United States
• Boehringer Ingelheim Investigational Site — Richmond, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.